Skip to main content



Local Cdiff information for Missouri

Missouri

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Missouri.



Local Cdiff information for Missouri

Missouri

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Missouri.

Providers


Dr. Jason G. Newland MD, MEd

Associate Professor of Pediatrics
St. Louis Children’s Hospital
1 Childrens Place
St. Louis, 63110
314-454-6050
FMT Provider: No

Dr. Wilfred Lee, MD

Cape Gastroenterology Specialists
28 S Mount Auburn Road
Cape Girardeau, 63701
(573) 331-3350
FMT Provider: Yes

Dr. Erik R. Dubberke, MD, MSPH

Associate Professor, Medicine, Division of Infectious Diseases
Washington University Infectious Diseases
620 S Taylor Ave
St. Louis, 63110
(314) 747-1206
FMT Provider: Yes

Regulation


C. diff Infections

Total Reported Cases: 1831
Hospital Onset: 1831
Community Onset: Not reported
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.77

Available Reports

Annual Progress based on SIR: 0.77

State Reporting Laws

Data Submission Required: No
Data Publicly Available: No
Data Validated: No
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: No
Law/Regulation: Not available

State Contact

Eric Hueste, Chief
Missouri Department of Health and Senior Services
930 Wildwood Drive
Jefferson City, 65102
573-751-6113
573-526-0235

CLINICAL TRIALS


RESTORATiVE303

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.

PRISM

Official Title: A Phase IIb, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AZD5148 for Prevention of Recurrence of Clostridioides Difficile Infection in Individuals 18 Years of Age and Above
Trial No. NCT07285213
Type: Interventional
Recruitment: Recruiting
Sponsor: AstraZeneca
Contact: See trial website for site-specific contacts
Gender: All
Age: 18 Years and older

BEETHOVEN

Official Title: A PHASE 3, PLACEBO-CONTROLLED, DOUBLE-BLINDED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF A CLOSTRIDIOIDES DIFFICILE VACCINE IN ADULTS 65 YEARS OF AGE AND OLDER
Trial No. NCT07282665
Type: Interventional
Recruitment: Recruiting
Sponsor: Pfizer
Contact: See trial website for site-specific contacts
Gender: All
Age: 65 Years and older